Literature DB >> 22406676

Allosteric modulation balances thermodynamic stability and restores function of ΔF508 CFTR.

Andrei A Aleksandrov1, Pradeep Kota, Liying Cui, Tim Jensen, Alexey E Alekseev, Santiago Reyes, Lihua He, Martina Gentzsch, Luba A Aleksandrov, Nikolay V Dokholyan, John R Riordan.   

Abstract

Most cystic fibrosis is caused by a deletion of a single residue (F508) in CFTR (cystic fibrosis transmembrane conductance regulator) that disrupts the folding and biosynthetic maturation of the ion channel protein. Progress towards understanding the underlying mechanisms and overcoming the defect remains incomplete. Here, we show that the thermal instability of human ΔF508 CFTR channel activity evident in both cell-attached membrane patches and planar phospholipid bilayers is not observed in corresponding mutant CFTRs of several non-mammalian species. These more stable orthologs are distinguished from their mammalian counterparts by the substitution of proline residues at several key dynamic locations in first N-terminal nucleotide-binding domain (NBD1), including the structurally diverse region, the γ-phosphate switch loop, and the regulatory insertion. Molecular dynamics analyses revealed that addition of the prolines could reduce flexibility at these locations and increase the temperatures of unfolding transitions of ΔF508 NBD1 to that of the wild type. Introduction of these prolines experimentally into full-length human ΔF508 CFTR together with the already recognized I539T suppressor mutation, also in the structurally diverse region, restored channel function and thermodynamic stability as well as its trafficking to and lifetime at the cell surface. Thus, while cellular manipulations that circumvent its culling by quality control systems leave ΔF508 CFTR dysfunctional at physiological temperature, restoration of the delicate balance between the dynamic protein's inherent stability and channel activity returns a near-normal state.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22406676      PMCID: PMC3891843          DOI: 10.1016/j.jmb.2012.03.001

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  59 in total

1.  Energy landscape along an enzymatic reaction trajectory: hinges or cracks?

Authors:  Paul Charles Whitford; José Nelson Onuchic; Peter Guy Wolynes
Journal:  HFSP J       Date:  2008-03-24

2.  Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

Authors:  W Dalemans; P Barbry; G Champigny; S Jallat; K Dott; D Dreyer; R G Crystal; A Pavirani; J P Lecocq; M Lazdunski
Journal:  Nature       Date:  1991 Dec 19-26       Impact factor: 49.962

3.  Thermodynamic effects of proline introduction on protein stability.

Authors:  Ravindra Singh Prajapati; Mili Das; Sridhar Sreeramulu; Minhajuddin Sirajuddin; Sankaranarayanan Srinivasan; Vaishnavi Krishnamurthy; Ranganathan Ranjani; C Ramakrishnan; Raghavan Varadarajan
Journal:  Proteins       Date:  2007-02-01

4.  Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant.

Authors:  Shane Atwell; Christie G Brouillette; Kris Conners; Spencer Emtage; Tarun Gheyi; William B Guggino; Jorg Hendle; John F Hunt; Hal A Lewis; Frances Lu; Irina I Protasevich; Logan A Rodgers; Rich Romero; Stephen R Wasserman; Patricia C Weber; Diana Wetmore; Feiyu F Zhang; Xun Zhao
Journal:  Protein Eng Des Sel       Date:  2010-02-11       Impact factor: 1.650

5.  Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR.

Authors:  F Zhang; N Kartner; G L Lukacs
Journal:  Nat Struct Biol       Date:  1998-03

6.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

7.  Ab initio folding of proteins with all-atom discrete molecular dynamics.

Authors:  Feng Ding; Douglas Tsao; Huifen Nie; Nikolay V Dokholyan
Journal:  Structure       Date:  2008-07       Impact factor: 5.006

8.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

9.  Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins.

Authors:  C L Ward; R R Kopito
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

10.  Emergence of protein fold families through rational design.

Authors:  Feng Ding; Nikolay V Dokholyan
Journal:  PLoS Comput Biol       Date:  2006-05-26       Impact factor: 4.475

View more
  43 in total

1.  Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity.

Authors:  Xuehong Liu; Nicolette O'Donnell; Allison Landstrom; William R Skach; David C Dawson
Journal:  Biochemistry       Date:  2012-06-15       Impact factor: 3.162

2.  Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains.

Authors:  Zhengrong Yang; Chi Wang; Qingxian Zhou; Jianli An; Ellen Hildebrandt; Luba A Aleksandrov; John C Kappes; Lawrence J DeLucas; John R Riordan; Ina L Urbatsch; John F Hunt; Christie G Brouillette
Journal:  Protein Sci       Date:  2014-05-03       Impact factor: 6.725

3.  The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation.

Authors:  Luigi Maiuri; Daniela De Stefano; Valeria Raia; Guido Kroemer
Journal:  Ann Transl Med       Date:  2015-05

4.  CFTR structure: lassoing cystic fibrosis.

Authors:  Bob Ford
Journal:  Nat Struct Mol Biol       Date:  2017-01-05       Impact factor: 15.369

5.  The N-terminal domain allosterically regulates cleavage and activation of the epithelial sodium channel.

Authors:  Pradeep Kota; Ginka Buchner; Hirak Chakraborty; Yan L Dang; Hong He; Guilherme J M Garcia; Jan Kubelka; Martina Gentzsch; M Jackson Stutts; Nikolay V Dokholyan
Journal:  J Biol Chem       Date:  2014-06-28       Impact factor: 5.157

6.  Thermal stability of purified and reconstituted CFTR in a locked open channel conformation.

Authors:  Luba A Aleksandrov; Timothy J Jensen; Liying Cui; Joseph N Kousouros; Lihua He; Andrei A Aleksandrov; John R Riordan
Journal:  Protein Expr Purif       Date:  2015-09-15       Impact factor: 1.650

7.  Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.

Authors:  Zhiwei Cai; Timea Palmai-Pallag; Pissared Khuituan; Michael J Mutolo; Clément Boinot; Beihui Liu; Toby S Scott-Ward; Isabelle Callebaut; Ann Harris; David N Sheppard
Journal:  J Physiol       Date:  2015-04-09       Impact factor: 5.182

Review 8.  Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability.

Authors:  P Andrew Chong; Pradeep Kota; Nikolay V Dokholyan; Julie D Forman-Kay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

9.  Ligand binding to a remote site thermodynamically corrects the F508del mutation in the human cystic fibrosis transmembrane conductance regulator.

Authors:  Chi Wang; Andrei A Aleksandrov; Zhengrong Yang; Farhad Forouhar; Elizabeth A Proctor; Pradeep Kota; Jianli An; Anna Kaplan; Netaly Khazanov; Grégory Boël; Brent R Stockwell; Hanoch Senderowitz; Nikolay V Dokholyan; John R Riordan; Christie G Brouillette; John F Hunt
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

Review 10.  Cystic fibrosis transmembrane conductance regulator (ABCC7) structure.

Authors:  John F Hunt; Chi Wang; Robert C Ford
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.